See background of NCD 32985.
See background of NCD 32984 for overall technology description.
This technology includes methods and placeholder peptides for the creation of peptide receptive HLA-A*68:02 and HLA-A*24:02 using TAPBPR in bacteria.
Peptide receptive MHC-I multimers of HLA-A*68:02 and HLA-A*24:02
Identification of peptide epitopes of HLA-A*68:02 and HLA-A*24:02
Specific placeholder peptides for the production of peptide receptive HLA-A*68:02 and HLA-A*24:02
|European Patent Office||Published Application||EP 4 136 098||02/22/2023||2020-284|
|United States Of America||Published Application||20210371499||12/20/2021||2020-284|
HLA-A*68:02, HLA-A*24:02, peptide receptive MHC-I